EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 233 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,100,080 | -65.6% | 323,553 | -25.6% | 0.00% | – |
| Q2 2023 | $3,195,523 | -48.4% | 434,765 | -27.3% | 0.00% | -100.0% |
| Q1 2023 | $6,191,975 | +79.0% | 597,681 | +104.1% | 0.00% | – |
| Q4 2022 | $3,458,335 | +7.1% | 292,831 | +90.4% | 0.00% | – |
| Q3 2022 | $3,229,000 | -50.9% | 153,805 | -27.4% | 0.00% | -100.0% |
| Q2 2022 | $6,574,000 | -61.4% | 211,790 | -48.9% | 0.00% | -50.0% |
| Q1 2022 | $17,015,000 | -16.1% | 414,419 | -11.2% | 0.00% | 0.0% |
| Q4 2021 | $20,282,000 | -32.3% | 466,567 | -22.1% | 0.00% | -33.3% |
| Q3 2021 | $29,972,000 | +84.0% | 598,565 | +131.4% | 0.00% | +50.0% |
| Q2 2021 | $16,291,000 | -47.0% | 258,638 | -21.9% | 0.00% | -33.3% |
| Q1 2021 | $30,765,000 | +31.9% | 331,128 | +27.2% | 0.00% | 0.0% |
| Q4 2020 | $23,320,000 | -7.9% | 260,271 | +6.3% | 0.00% | 0.0% |
| Q3 2020 | $25,310,000 | -0.6% | 244,948 | -23.9% | 0.00% | -25.0% |
| Q2 2020 | $25,463,000 | +53.1% | 321,997 | +12.0% | 0.00% | +33.3% |
| Q1 2020 | $16,635,000 | +21.8% | 287,501 | +13.5% | 0.00% | +50.0% |
| Q4 2019 | $13,663,000 | -11.2% | 253,276 | -13.9% | 0.00% | 0.0% |
| Q3 2019 | $15,379,000 | +9.1% | 294,168 | +0.9% | 0.00% | 0.0% |
| Q2 2019 | $14,091,000 | -2.5% | 291,659 | +2.0% | 0.00% | 0.0% |
| Q1 2019 | $14,452,000 | -13.3% | 286,055 | +1.7% | 0.00% | -33.3% |
| Q4 2018 | $16,671,000 | -0.5% | 281,234 | +10.5% | 0.00% | 0.0% |
| Q3 2018 | $16,763,000 | +2.7% | 254,621 | -21.2% | 0.00% | 0.0% |
| Q2 2018 | $16,317,000 | +4.0% | 323,181 | +8.5% | 0.00% | 0.0% |
| Q1 2018 | $15,686,000 | +61.9% | 297,942 | +42.9% | 0.00% | +50.0% |
| Q4 2017 | $9,690,000 | -26.0% | 208,500 | -35.6% | 0.00% | 0.0% |
| Q3 2017 | $13,097,000 | +59.7% | 323,769 | +33.8% | 0.00% | 0.0% |
| Q2 2017 | $8,202,000 | +20.2% | 241,907 | +3.0% | 0.00% | +100.0% |
| Q1 2017 | $6,821,000 | +16.5% | 234,902 | +31.8% | 0.00% | 0.0% |
| Q4 2016 | $5,855,000 | +51.2% | 178,276 | +45.2% | 0.00% | 0.0% |
| Q3 2016 | $3,872,000 | +2.1% | 122,774 | -9.0% | 0.00% | 0.0% |
| Q2 2016 | $3,794,000 | -21.1% | 134,921 | +1.9% | 0.00% | 0.0% |
| Q1 2016 | $4,811,000 | -2.4% | 132,363 | +7.4% | 0.00% | 0.0% |
| Q4 2015 | $4,931,000 | +51.0% | 123,246 | +7.5% | 0.00% | 0.0% |
| Q3 2015 | $3,266,000 | +117.3% | 114,615 | +151.3% | 0.00% | – |
| Q2 2015 | $1,503,000 | +4910.0% | 45,607 | +4358.2% | 0.00% | – |
| Q1 2015 | $30,000 | -88.6% | 1,023 | -89.4% | 0.00% | – |
| Q4 2014 | $264,000 | +347.5% | 9,677 | +251.9% | 0.00% | – |
| Q3 2014 | $59,000 | -53.9% | 2,750 | -51.9% | 0.00% | – |
| Q2 2014 | $128,000 | -56.8% | 5,717 | -51.1% | 0.00% | – |
| Q1 2014 | $296,000 | -59.3% | 11,698 | -63.1% | 0.00% | – |
| Q4 2013 | $728,000 | +114.7% | 31,674 | +78.1% | 0.00% | – |
| Q3 2013 | $339,000 | -51.4% | 17,780 | -63.2% | 0.00% | – |
| Q2 2013 | $697,000 | – | 48,338 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Laurus Investment Counsel Inc. | 120,504 | $10,797,000 | 4.20% |
| SNYDER CAPITAL MANAGEMENT L P | 723,477 | $64,824,000 | 2.12% |
| Hillcrest Asset Management LLC | 161,428 | $14,464,000 | 1.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 587,727 | $52,660,000 | 1.85% |
| PALISADE CAPITAL MANAGEMENT, LP | 579,009 | $51,879,000 | 1.33% |
| Pier Capital, LLC | 109,786 | $9,837,000 | 1.04% |
| Paradiem, LLC | 21,320 | $2,286,000 | 0.97% |
| EARNEST PARTNERS LLC | 1,390,735 | $124,610,000 | 0.86% |
| Ridgewood Investments LLC | 10,004 | $1,034,000 | 0.82% |
| Tygh Capital Management, Inc. | 56,334 | $5,048,000 | 0.78% |